基亞生物科技股份有限公司／Medigen Biotech Corp.
基亞生物科技股份有限公司／Medigen Biotech Corp.
  • About
    • Company Overview
    • Our Vision
    • Management
    • Careers
    • Subsidiaries
      • Medigen Vaccine Biologics Corporation
      • TBG Diagnostics Limited
      • Winston Medical & Biotech Group
  • Business
    • Cell Therapy Technology
      • Cell Therapy Regulation in Taiwan
      • Magicell–NK (Natural killer cells)
      • Cell Processing Facility in Taiwan
    • Drug Development
      • PI-88 (MUPARFOSTAT)
      • OBP-301
    • Drug Discovery
      • Monoclonal Antibody
    • Vaccine
    • Molecular Diagnostics
    • Generic Drugs
  • COVID-19
  • News
  • Investors
    • Financial Statement
    • Shareholder Services
  • Contact us
  • Language
    • 中文 (繁)
    • English
    • 中文 (简)
  • 1460x580_01-1
  • 1460X450_1-1
  • INDEX_1460x450-06
  • 2019企業影片_英文無字幕.mp4_000136.9881920x763
  • 2019企業影片_英文無字幕.mp4_000200.9871920x763
  • 1232

Cell Therapy Technology

Our Drug Pipeline

Vaccine

Molecular Diagnostics

Generic Drugs
14F., No.3, Park St., Nangang Dist., Taipei City 11503, Taiwan (R.O.C)‧Copyright© 2020 Medigen Biotechnology Corp. All rights reserved.